Jikui Guan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancers

Science signaling

JCO precision oncology

University of Gothenburg

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Gothenburg Sep 01 2016

Sweden

Assistant Professor :: Medical Biochemistry and Cell Biology

University of Gothenburg Jan 01 2015 - Aug 31 2016

Sweden

researcher :: Medical Biochemistry and Cell Biology

Umeå University Jan 01 2013 - Dec 31 2014

Sweden

postdoc :: Molecular Biology

Umeå University Oct 01 2009 - Dec 31 2012

Sweden

postdoc :: UCMM

Beijing Yanjing Zhongke Bio-tech Co Ltd

China

Project Leader

Education History

Karolinska Institutet

Sweden

PHD :: Cell and Molecular Biology

Chinese Academy of Medical Sciences and Peking Union Medical College

China

MSC :: Cell Biology

Shandong University

China

BSC :: Microbiology

Publications

Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Jikui Guan, Marcus Borenäs, Junfeng Xiong, Wei-Yun Lai, Ruth H Palmer, Bengt Hallberg
IGF1R Contributes to Cell Proliferation in ALK -Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. Cancers 15 (17) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Diana Treis, Ganesh Umapathy, Susanne Fransson, Jikui Guan, Patricia Mendoza-García, Joachim Tetteh Siaw, Sandra Wessman, Lena Gordon Murkes, Jakob J E Stenman, Anna Djos, Lotta H M Elfman, John Inge Johnsen, Bengt Hallberg, Ruth H Palmer, Tommy Martinsson, Per Kogner
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation. JCO precision oncology 6 (2022)
Jikui Guan, Bengt Hallberg, Ruth H Palmer
Chromosome Imbalances in Neuroblastoma-Recent Molecular Insight into Chromosome 1p-deletion, 2p-gain, and 11q-deletion Identifies New Friends and Foes for the Future. Cancers 13 (23) (2021)
Joachim T Siaw, Jonatan L Gabre, Ezgi Uçkun, Marc Vigny, Wancun Zhang, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer, Jikui Guan
Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells. Cancers 13 (8) (2021)
Andrey Fadeev, Patricia Mendoza-Garcia, Uwe Irion, Jikui Guan, Kathrin Pfeifer, Stephanie Wiessner, Fabrizio Serluca, Ajeet Pratap Singh, Christiane Nüsslein-Volhard, Ruth H Palmer
ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells. Proceedings of the National Academy of Sciences of the United States of America 115 (4) (2018)
Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H Palmer, Bengt Hallberg
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways. Science signaling 11 (557) (2018)
Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, Diana Treis, Jimmy Van den Eynden, Damini Chand, Ganesh Umapathy, Kristina Ruuth, Petter Svenberg, Sandra Wessman, Alia Shamikh, Hans Jacobsson, Lena Gordon, Jakob Stenman, Pär-Johan Svensson, Magnus Hansson, Erik Larsson, Tommy Martinsson, Ruth H Palmer, Per Kogner, Bengt Hallberg
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor molecular case studies 4 (4) (2018)
Jikui Guan, Yasuo Yamazaki, Damini Chand, Jesper R van Dijk, Kristina Ruuth, Ruth H Palmer, Bengt Hallberg
Novel Mechanisms of ALK Activation Revealed by Analysis of the Y1278S Neuroblastoma Mutation. Cancers 9 (11) (2017)
Ganesh Umapathy, Jikui Guan, Dan Emil Lind, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H Palmer, Bengt Hallberg
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Science signaling 10 (507) (2017)

Jikui Guan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jikui Guan